Phase II study of nab-paclitaxel in refractory small bowel adenocarcinoma and CpG island methylator phenotype (CIMP)-high colorectal cancer

Guardat en:
Dades bibliogràfiques
Publicat a:Ann Oncol
Autors principals: Overman, M J, Adam, L, Raghav, K, Wang, J, Kee, B, Fogelman, D, Eng, C, Vilar, E, Shroff, R, Dasari, A, Wolff, R, Morris, J, Karunasena, E, Pisanic, T R, Azad, N, Kopetz, S
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2019
Matèries:
Corrigenda
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6442652/
https://ncbi.nlm.nih.gov/pubmed/29982323
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdy221
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars